GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, AKR1B1, ALOX15, BCL2, CA12, CA2, CA7, CDK6, CHRM1, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, F10, F3, FABP3, FABP4, GPR35, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MAOB, MET, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.64138 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, BCL2, CA2, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, PPARA, SMAD3, SRC, TEK, TYR |
8.02036 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA, TBXAS1 |
7.78891 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IGF1R, INSR, MAOB, PPARA, SRC, TEK, TYR |
7.38838 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, MAOB, SRC, TYR |
7.29506 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.06975 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, PDE5A, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.96717 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, PDE5A, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.96538 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, ALPL, BCL2, CA2, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, PPARA, SMAD3, SRC, TEK, TYR |
6.87402 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
6.67486 |
[BP] GO:0048513 |
animal organ development
|
ACHE, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, HSD11B1, HSD17B2, INSR, KDR, PPARA, PTPRS, SMAD3, SRC, TEK, TYR |
6.54046 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.39725 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.31196 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.3011 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, INSR, MAOB, PPARA, SRC, TEK |
6.26143 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.16003 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, AOX1, CA1, CA12, CA2, CA4, CA6, CA7, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GBA2, HSPA1A, PDE5A, PPARA, TBXAS1, TYR, XDH |
6.11091 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, PPARA, PTPN1, PTPRS, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TYR, XDH |
5.93575 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, HSD11B2, MAOB, SRC, TEK, TYR |
5.76912 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7 |
5.73807 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX15, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, PDE5A, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.68273 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FUT7, GBA2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, PPARA, PTPN1, PTPRS, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TYR, XDH |
5.64729 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, IGF1R, INSR, MAOB, PPARA, SMAD3, SRC, TEK |
5.6371 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MAOB, TBXAS1, TYR, XDH |
5.40624 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, CDK6, CNR1, CNR2, CYP19A1, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MET, NUAK1, PPARA, PTPN1, PTPRS, SMAD3, SRC, TEK, XDH |
5.24941 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ALOX15, BCL2, CA2, CA7, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, PPARA, PTPN1, SMAD3, SRC, TEK |
5.22788 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, ALPL, BCL2, CA2, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, GBA2, HSD11B1, HSD17B2, INSR, KDR, MAOB, PPARA, PTPRS, SMAD3, SRC, TEK, TYR |
5.21802 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, AKR1B1, ALOX15, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, PDE5A, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.21802 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, AKR1B1, ALOX15, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, F3, FABP4, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PPARA, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.20388 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, F3, FABP3, HSPA1A, IGF1R, INSR, KDR, NUAK1, PDE5A, SMAD3, SRC, TEK, XDH |
5.20388 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.09201 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, EGFR, F10, F3, GPR35, HSPA1A, INSR, KDR, MET, PDE5A, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.06671 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, BCL2, CYP1B1, EGFR, F10, F3, GPR35, HSPA1A, INSR, KDR, MET, PDE5A, PTPN1, SRC, TEK, XDH |
4.97227 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, ALPL, BCL2, CA2, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FUT7, GBA2, HSD11B1, HSD17B2, INSR, KDR, MAOB, MET, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS2, TYR |
4.97033 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, TBXAS1 |
4.83848 |
[BP] GO:0040012 |
regulation of locomotion
|
BCL2, CDK6, CHRM1, CHRM4, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.73667 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MAOB, SRC |
4.64834 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.54346 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX15, BCL2, CDK6, CNR1, CNR2, CYP19A1, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, PPARA, PTPN1, PTPRS, SMAD3, SRC, TEK, XDH |
4.53045 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PTPN1, SRC, TEK, XDH |
4.48848 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.44881 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, F3, FABP4, GPR35, HSPA1A, INSR, KDR, MET, PDE5A, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.4369 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FUT7, GBA2, MET, PPARA, TBXAS1 |
4.34925 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, BCL2, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, EGFR, FABP3, HSD11B2, KDR, MAOB, SRC |
4.23597 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.23597 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX15, ALPL, BCL2, CHRM1, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, IGF1R, INSR, MET, PDE5A, PPARA, SMAD3, SRC, TEK, TNKS2, TYR |
4.08742 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.00767 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PTPN1, PTPRS, SRC, TEK, TNKS, XDH |
4.00767 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM4 |
3.89613 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.88831 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.78739 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.76837 |
[BP] GO:0032844 |
regulation of homeostatic process
|
BCL2, CA2, CA7, CDK6, CNR1, EGFR, HCAR2, KDR, SRC, TNKS, TNKS2 |
3.76357 |
[BP] GO:2000145 |
regulation of cell motility
|
BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.75296 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
3.75296 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PTPN1, PTPRS, SRC, TEK, TNKS, XDH |
3.7428 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.70001 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM4 |
3.69173 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
EGFR, F10, F3, INSR, MET, SRC, TEK |
3.64454 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, TBXAS1 |
3.5963 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, KDR, MAOB, SRC |
3.58376 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.54692 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, TBXAS1 |
3.53851 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.51779 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.51779 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, BCL2, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PPARA, PTPN1, PTPRS, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TYR, XDH |
3.51669 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, AKR1B1, ALOX15, ALPL, BCL2, CA2, CA6, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, F10, F3, FABP3, FABP4, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TYR |
3.51218 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, MAOB |
3.51218 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, MAOB, TYR |
3.51218 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, KDR, SMAD3, SRC, TEK |
3.49623 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, FABP3, PPARA |
3.48483 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, TBXAS1 |
3.48483 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, HCAR2, HSPA1A, IGF1R, KDR, MET, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
3.48483 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, BCL2, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, PPARA, PTPN1, PTPRS, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TYR, XDH |
3.48364 |
[BP] GO:0051270 |
regulation of cellular component movement
|
BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.46718 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A, MAOB |
3.46718 |
[BP] GO:0030334 |
regulation of cell migration
|
BCL2, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.42867 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, BCL2, CHRM1, CHRM4, CYP1A1, EGFR, ESR1, MET, SRC, TEK, TYR |
3.40311 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CNR1, CNR2, CYP19A1, EGFR, ESR1, F3, FABP4, KDR, MET, PPARA, PTPRS, SMAD3, TEK |
3.37728 |
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.37564 |
[BP] GO:0031347 |
regulation of defense response
|
CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, PPARA, PTPN1, PTPRS, SMAD3, SRC, TEK |
3.36089 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, HCAR2, HSPA1A, IGF1R, KDR, MET, PTPN1, SMAD3, SRC, TEK, XDH |
3.35813 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CDK6, CYP1B1, DUSP3, KDR, NUAK1, PDE5A, PPARA, SMAD3, SRC, TEK |
3.32521 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ALOX15, BCL2, CYP1A1, EGFR, PPARA, SMAD3 |
3.30627 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, F10, F3, FUT7, GBA2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, PPARA, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
3.29196 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, CNR1, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
3.25648 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR, MAOB |
3.24157 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.22911 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MAOB, MET, PDE5A, PPARA, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.22568 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, IGF1R, INSR, KDR, NUAK1, PDE5A, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
3.2124 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, ALOX15, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HCAR2, HSPA1A, IGF1R, KDR, MAOB, MET, PDE5A, PPARA, PTPN1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.2124 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, CDK6, KDR, SMAD3, SRC, TEK |
3.2124 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
BCL2, CA2, CDK6, CHRM1, CHRM2, CNR1, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, PDE5A, PTPRS, SMAD3, SRC, TEK, TNKS2, XDH |
3.20481 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.20401 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, IGF1R, INSR, KDR, NUAK1, PDE5A, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
3.1783 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, CNR1, CNR2 |
3.15697 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.13183 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.13183 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.13183 |
[BP] GO:0046777 |
protein autophosphorylation
|
CSNK2A1, EGFR, IGF1R, INSR, KDR, SRC, TEK |
3.11972 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.11836 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, BCL2, CNR2, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, PTPN1, PTPRS, SMAD3, SRC, XDH |
3.10514 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, BCL2, CNR2, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, PTPN1, PTPRS, SMAD3, SRC, XDH |
3.09399 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.07565 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, PDE5A, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.05867 |
[BP] GO:0050727 |
regulation of inflammatory response
|
CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, PPARA, SMAD3, TEK |
3.00201 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, BCL2, HSPA1A, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.97973 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, HSPA1A, IGF1R, INSR, KDR, SMAD3, SRC |
2.96297 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, TBXAS1 |
2.95998 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, EGFR, ESR1, F3, IGF1R, INSR, KDR, TEK |
2.93562 |
[BP] GO:0045759 |
None
|
CNR1, CNR2, GPR35 |
2.92142 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, HCAR2, HSPA1A, IGF1R, KDR, PTPN1, SMAD3, SRC, TEK, XDH |
2.9008 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, CNR1, CNR2, EGFR, FABP3, HSD11B2, IGF1R, INSR, PPARA, SRC, TEK, TYR |
2.88472 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, GPR35, HSPA1A, IGF1R, INSR, MET, NUAK1, PDE5A, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
2.88126 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ALOX15, BCL2, CA2, CA7, CHRM1, CNR1, CYP19A1, EGFR, GPR35, HCAR2, HSPA1A, INSR, MAOB, PPARA, PTPN1, SMAD3, SRC |
2.88126 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, HSD11B2, MAOB, SRC |
2.86458 |
[BP] GO:0002682 |
regulation of immune system process
|
ALOX15, BCL2, CA2, CDK6, CNR1, CNR2, CYP19A1, DUSP3, ESR1, ESRRA, HCAR2, HSPA1A, PDE5A, PTPN1, PTPRS, SMAD3, SRC |
2.83125 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.83125 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALOX15, BCL2, CDC25B, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, PDE5A, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.81497 |
[BP] GO:0009894 |
regulation of catabolic process
|
BCL2, CNR1, CSNK2A1, EGFR, ESRRB, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
2.81195 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.81091 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, BCL2, CDK6, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, IGF1R, INSR, KDR, SMAD3, SRC |
2.80386 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, CNR1, EGFR, HCAR2, TNKS, TNKS2 |
2.80386 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, BCL2, CA1, CA2, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.80386 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MAOB |
2.77953 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.7544 |
[BP] GO:0006468 |
protein phosphorylation
|
BCL2, CDC25B, CDK6, CSNK2A1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS |
2.72628 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, HSD11B2, MAOB, SRC |
2.7248 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, TBXAS1 |
2.7248 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, FABP3, PPARA |
2.72096 |
[BP] GO:0050790 |
regulation of catalytic activity
|
BCL2, CDC25B, CNR1, CNR2, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, INSR, NUAK1, PDE5A, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
2.71375 |
[BP] GO:0051701 |
interaction with host
|
EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
2.68813 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
CDK6, KDR, SMAD3, TEK |
2.68813 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.68132 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, PPARA, PTPN1, SMAD3, SRC, TEK |
2.68092 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, BCL2, CDC25B, EGFR, ESRRB, FABP3, INSR, KDR, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
2.67713 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, BCL2, CDC25B, EGFR, ESRRB, FABP3, INSR, KDR, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
2.67713 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, PDE5A, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.67196 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.66099 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, XDH |
2.65011 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, CNR1, CNR2, EGFR, FABP3, HSD11B2, IGF1R, INSR, PPARA, SRC, TEK, TYR |
2.64122 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM4 |
2.62088 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.58703 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH |
2.56206 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, HSD11B2, IGF1R, INSR, PPARA, SRC, TEK |
2.56206 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, HSD11B2, PPARA, SMAD3, SRC, TEK |
2.49258 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, DUSP3, EGFR, IGF1R, INSR, KDR, PDE5A, PTPN1, SRC, TEK, XDH |
2.48396 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.4838 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.48201 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.48201 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
ALOX15, CDK6, KDR, SMAD3, TEK |
2.46953 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
BCL2, CNR1, EGFR, HCAR2, MET, PPARA, SMAD3 |
2.46557 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.45423 |
[BP] GO:0044092 |
negative regulation of molecular function
|
CNR1, CNR2, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, PPARA, PTPN1, SRC, TNKS |
2.4492 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, PTPN1, SMAD3, SRC, TEK |
2.44763 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, SRC |
2.44763 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.44763 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.44763 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, BCL2, CNR1, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.44763 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.44763 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.44763 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, HSD11B2, PPARA, SMAD3, SRC, TEK |
2.44763 |
[BP] GO:0032787 |
None
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, PPARA, TBXAS1 |
2.44763 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.44188 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP4, IGF1R, INSR, KDR, PDE5A, PPARA, PTPN1, SRC, TEK, XDH |
2.44188 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.42636 |
[BP] GO:0050793 |
regulation of developmental process
|
BCL2, CA2, CDK6, CNR1, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, INSR, KDR, NUAK1, PDE5A, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS2, XDH |
2.40363 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DUSP3, EGFR, KDR, PTPN1, SRC, TEK |
2.38981 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.3725 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, BCL2, CA12, CA2, CA7, CNR1, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3, SRC |
2.36772 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, CNR1, CNR2, CYP1A1, CYP1A2, MAOB, SRC |
2.36772 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, TEK |
2.36715 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, EGFR, F3, FABP4, KDR, MET, SMAD3 |
2.35287 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
CNR2, CYP19A1, PPARA, SMAD3, TEK |
2.35287 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.33239 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, EGFR, ESR1, MET, SMAD3, SRC |
2.33014 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, HSPA1A, IGF1R, INSR, KDR, MET, PDE5A, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.31677 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.28111 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, EGFR, INSR, KDR, PDE5A, PTPN1, SRC, TEK, XDH |
2.27295 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, BCL2, CDC25B, EGFR, ESR1, ESR2, F3, HSPA1A, INSR, MET, PDE5A, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
2.27086 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, HSD11B2, PPARA, SMAD3, SRC, TEK |
2.25906 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DUSP3, ESR1, HSPA1A, IGF1R, MET, PTPN1, SRC, XDH |
2.23948 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM4 |
2.23433 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.23433 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM4 |
2.23433 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, CNR1, CNR2, CYP1A1, CYP1A2, MAOB, SRC |
2.22164 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
CDK6, DUSP3, EGFR, HSPA1A, IGF1R, MET, NUAK1, PTPN1, PTPRS, XDH |
2.2202 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.21962 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.21962 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.21962 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.21962 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.21962 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CNR1, CYP1A1, EGFR, HSD11B2, SRC, TYR |
2.21829 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ALOX15, CDK6, CNR1, CNR2, CYP19A1, DUSP3, PDE5A, PTPRS |
2.21516 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.20202 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
BCL2, CDC25B, CDK6, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, SMAD3, TNKS |
2.18778 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.15267 |
[BP] GO:0043207 |
response to external biotic stimulus
|
ALPL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, MAOB, SMAD3, SRC |
2.14275 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.14275 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ALOX15, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, F3, HSPA1A, INSR, KDR, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
2.14275 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.13548 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, PPARA, PTPN1, PTPRS, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TUBB3, TYR, XDH |
2.11806 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.11646 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.1138 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.1138 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.06859 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM4 |
2.06859 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, HSPA1A, MAOB, PDE5A, SRC, XDH |
2.06252 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, BCL2, CNR1, CYP1A1, EGFR, HSD11B2, SRC, TYR |
2.0604 |
[BP] GO:2000241 |
regulation of reproductive process
|
CNR1, ESR1, INSR, PDE5A, SRC |
2.05912 |
[BP] GO:0032868 |
None
|
FABP3, HSD11B2, INSR, PPARA, SRC |
2.05144 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, HSD11B2, MAOB |
2.05144 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.05144 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.05144 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.05144 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.05144 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.04101 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALOX15, BCL2, CDC25B, EGFR, ESRRB, INSR, KDR, PDE5A, PTPN1, SRC, TEK, XDH |
2.03749 |
[BP] GO:0016310 |
phosphorylation
|
BCL2, CDC25B, CDK6, CSNK2A1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS |
2.02093 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, MAOB, SMAD3, SRC |
2.01907 |
[BP] GO:0050678 |
None
|
CDK6, EGFR, F3, KDR, SMAD3, TEK, XDH |
2.00022 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ALOX15, ALPL, BCL2, CA12, CA14, CA2, CA4, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, F10, F3, FUT7, GBA2, GPR35, HCAR2, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, MAOB, MET, PTPN1, PTPRS, SRC, TBXAS1, TEK, TYR |
3.04168 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ALOX15, ALPL, BCL2, CA12, CA14, CA2, CA4, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, F10, F3, FUT7, GBA2, GPR35, HCAR2, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, MAOB, MET, PTPN1, PTPRS, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TYR |
2.60003 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.3827 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ALOX15, ALPL, CA12, CA14, CA2, CA4, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, EGFR, ESR1, F10, F3, GBA2, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PTPN1, PTPRS, SMAD3, SRC, TEK |
2.34494 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
CA4, CHRM1, CHRM2, CHRM4, CNR1, CNR2, F10, F3, GPR35, IGF1R, INSR, KDR, MET, PTPRS, TEK |
2.07364 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, CA2, CA4, CHRM1, CHRM2, CHRM4, CNR1, EGFR, INSR, MET, SRC, TEK |
2.06272 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, F10, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, PTPN1, PTPRS, SRC, TBXAS1, TEK, TNKS, TNKS2, TUBB3, TYR, XDH |
9.7722 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
9.64138 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, AOX1, CA1, CA12, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, PPARA, PTPN1, SMAD3, TBXAS1, TNKS, TYR, XDH |
8.70768 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, PPARA, PTPN1, PTPRS, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TUBB3, TYR, XDH |
7.51097 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MAOB, TBXAS1, TYR, XDH |
6.48253 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
6.16003 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
6.10884 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
5.35564 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, TEK |
4.51889 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, XDH |
4.50068 |
[MF] GO:0038023 |
signaling receptor activity
|
CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
4.39858 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, CDK6, CHRM1, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PPARA, SRC, TEK |
4.23597 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.21448 |
[MF] GO:0060089 |
molecular transducer activity
|
CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
4.10091 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, TEK |
4.00138 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM4 |
3.89613 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
3.80796 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA6, CA7, ESR1, ESR2, ESRRA, ESRRB, PPARA, PTPN1, SMAD3, TNKS |
3.80058 |
[MF] GO:0004871 |
signal transducer activity
|
CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, SMAD3, TEK |
3.7428 |
[MF] GO:0004872 |
receptor activity
|
CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
3.73643 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B2, HSD17B1, MAOB, SRC, TBXAS1, XDH |
3.72867 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.72867 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.72867 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR |
3.64454 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.57612 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.43187 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.43035 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, XDH |
3.41892 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.37837 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA |
3.29009 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.288 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.288 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
3.24938 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.24237 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC, TBXAS1 |
3.10514 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, AOX1, CDK6, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, PTPRS, SRC, TEK, TUBB3, XDH |
3.07565 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC, TBXAS1 |
2.94749 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
2.83125 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.81091 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.81091 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR |
2.7248 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.71752 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.68813 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, NUAK1, PDE5A, PPARA, PTPN1, SMAD3, TBXAS1, TNKS, TNKS2, TYR, XDH |
2.67293 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SMAD3 |
2.62461 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM4 |
2.48201 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.44763 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, AOX1, CDK6, CSNK2A1, EGFR, FABP3, FABP4, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, SRC, TEK, TUBB3, XDH |
2.43165 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AOX1, CDK6, CSNK2A1, EGFR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, SRC, TEK, TUBB3, XDH |
2.31267 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AOX1, CDK6, CSNK2A1, EGFR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, SRC, TEK, TUBB3, XDH |
2.31172 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, NUAK1, PDE5A, PPARA, PTPN1, SMAD3, TBXAS1, TNKS, TNKS2, TYR, XDH |
2.2944 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.21962 |
[MF] GO:0004672 |
protein kinase activity
|
CDK6, CSNK2A1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
2.21516 |
[MF] GO:0099600 |
transmembrane receptor activity
|
CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, TEK |
2.21516 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, TEK |
2.21516 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.15533 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.05144 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.05144 |